Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

Shanshan Pei, Kevin Callahan, PhD, Mohammad Minhajuddin, PhD, Marlene Balys, Sarah Neering, Cheryl Corbett, Michael W. Becker, MD, Jane L. Liesveld, MD, Fred Hagen, PhD, Alan E Friedman, PhD, Peter Crooks, PhD, Craig T. Jordan, PhD

Blood (2011) 118 (21): 3506.

https://doi.org/10.1182/blood.V118.21.3506.3506

Published: 2011

Journal Articles

High Resolution Epigenomic Profiling of Loss of Heterozygosity in MDS Reveals an Important Role of DNA Methylation in Regulating Expression of Genes in the Deleted Regions of Chromosomes 5q, 7q and 20q.

D. Sohal, J. Opalinska, L. Zhou, P. Pahanish, E. Friedman, R. Thompson, K. Ye, M. Figueroa, A. Melnick, J. Greally, A. List, A. Verma

Blood (2007) 110 (11): 2120.

https://doi.org/10.1182/blood.V110.11.2120.2120

Published: 2007

Journal Articles

Inhibition of the TGF-β Receptor I Can Stimulate Hematopoiesis in Primary Myelodysplastic Syndrome Progenitors as Well as in TGF-β Driven Transgenic Mouse Model of Bone Marrow Failure.

L. Zhou, A. Nguyen, P. Pahanish, J. Hayman, K. Gundabolu, A. Chubak, S. Parmar, D. Garry, A. Wickrema, T. Navas, L. Higgins, E. Friedman, A. List, M. Bitzer, A. Verma

Blood (2007) 110 (11): 2443.

https://doi.org/10.1182/blood.V110.11.2443.2443

Published: 2007

Journal Articles

Global DNA Methylation Profiling Demonstrates That Idiopathic Myelofibrosis Is Characterized by a Distinct Epigenetic Signature with Aberrant Methylation Changes in Genes Involved in Inflammation and Hematopoiesis

J. Opalinska, D. Sohal, R. Thompson, L. Zhou, Y. Li, P. Pahanish, V. Kotla, S. Kambhampati, S. Parmar, E. Friedman, M. Figueroa, K. Ye, A. Wickrema, A. Melnick, J. Greally, A. Pardanani, A. Verma

Blood (2007) 110 (11): 1536.

https://doi.org/10.1182/blood.V110.11.1536.1536

Published: 2007

Journal Articles

Global Epigenomic Profiling Demonstrates That Myelodysplasia Is Characterized by a Distinct Epigenetic Signature with Aberrant DNA Methylation Changes Involving Various Malignant and Hematopoietic Pathways.

L. Zhou, J. Opalinska, D. Sohal, R. Thompson, Y. Li, V. Kotla, P. Pahanish, S. Parmar, S. Kambhampati, M. Figueroa, K. Ye, E. Friedman, A. Wickrema, A. Melnick, J. Greally, A. Verma

Blood (2007) 110 (11): 2436.

https://doi.org/10.1182/blood.V110.11.2436.2436

Published: 2007

Journal Articles

Timing between Rituximab and 90 Y-Ibritumomab Tiuxetan in Pts with Non-Hodgkin’s Lymphoma Does Not Affect Clinical Outcomes.

Isaiah E. Friedman, Charalambos Andreadis, Yumi Taylor Diangi, Sunita D. Nasta, Selina M. Luger, Edward A. Stadtmauer, Stephen J. Schuster

Blood (2006) 108 (11): 4735.

https://doi.org/10.1182/blood.V108.11.4735.4735

Published: 2006

NARROW

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

High Resolution Epigenomic Profiling of Loss of Heterozygosity in MDS Reveals an Important Role of DNA Methylation in Regulating Expression of Genes in the Deleted Regions of Chromosomes 5q, 7q and 20q.

Inhibition of the TGF-β Receptor I Can Stimulate Hematopoiesis in Primary Myelodysplastic Syndrome Progenitors as Well as in TGF-β Driven Transgenic Mouse Model of Bone Marrow Failure.

Global DNA Methylation Profiling Demonstrates That Idiopathic Myelofibrosis Is Characterized by a Distinct Epigenetic Signature with Aberrant Methylation Changes in Genes Involved in Inflammation and Hematopoiesis

Global Epigenomic Profiling Demonstrates That Myelodysplasia Is Characterized by a Distinct Epigenetic Signature with Aberrant DNA Methylation Changes Involving Various Malignant and Hematopoietic Pathways.

Timing between Rituximab and 90 Y-Ibritumomab Tiuxetan in Pts with Non-Hodgkin’s Lymphoma Does Not Affect Clinical Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

High Resolution Epigenomic Profiling of Loss of Heterozygosity in MDS Reveals an Important Role of DNA Methylation in Regulating Expression of Genes in the Deleted Regions of Chromosomes 5q, 7q and 20q.

Inhibition of the TGF-β Receptor I Can Stimulate Hematopoiesis in Primary Myelodysplastic Syndrome Progenitors as Well as in TGF-β Driven Transgenic Mouse Model of Bone Marrow Failure.

Global DNA Methylation Profiling Demonstrates That Idiopathic Myelofibrosis Is Characterized by a Distinct Epigenetic Signature with Aberrant Methylation Changes in Genes Involved in Inflammation and Hematopoiesis

Global Epigenomic Profiling Demonstrates That Myelodysplasia Is Characterized by a Distinct Epigenetic Signature with Aberrant DNA Methylation Changes Involving Various Malignant and Hematopoietic Pathways.

Timing between Rituximab and 90 Y-Ibritumomab Tiuxetan in Pts with Non-Hodgkin’s Lymphoma Does Not Affect Clinical Outcomes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only